Phase 1 Hypertension trials recruiting now

All Hypertension trials, every phase

Other phases for Hypertension

Phase 1 Hypertension trials

• : Vascular Function in Health and Disease
  NCT02966665 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
  NCT07632235 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy.
  NCT07593027 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 29 locations
• A Pilot Study of Microbiota Transplant With Antibiotic Preconditioning and Fiber Supplementation in Pulmonary Arterial Hypertension (GUT RESTORE-PAH)
  NCT06481852 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
  NCT06267274 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers
  NCT07682948 · Phase: Phase 1 · Ages: 19 Years to 54 Years · Sex: All (male and female) · 1 location
• A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial Hypertension
  NCT06872112 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）
  NCT07368608 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 2 locations
• A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
  NCT07143448 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
  NCT07428473 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
  NCT06554301 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months
  NCT07282171 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: Female · 3 locations
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
  NCT06649110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 87 locations
• A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
  NCT07758634 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
  NCT05369065 · Phase: Phase 1 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 3 locations
• Addressing Gaps in the Hypertension and Diabetes Care Continuum in Rural Bangladesh: The Dinajpur Study
  NCT06258473 · Phase: Phase 1 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
  NCT05363761 · Phase: Phase 1 · Ages: 21 Years to 65 Years · Sex: All (male and female) · 6 locations
• Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
  NCT06821685 · Phase: Phase 1 · Ages: 22 Years to 40 Years · Sex: Female · 1 location
• Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
  NCT06770023 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
  NCT06947460 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 65 Years · Sex: All (male and female) · 1 location
• Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project
  NCT05989581 · Phase: Phase 1 · Ages: 14 Years to 89 Years · Sex: Female · 1 location
• DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
  NCT07623525 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
  NCT06826859 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 55 Years · Sex: Female · 1 location
• EUS Guided Portal-systemic Pressure Gradient Measurement
  NCT04633356 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Effect of Dexmedetomidine on Hemodynamic Response to Endotracheal Intubation in Hypertensive Patients
  NCT06712186 · Phase: Phase 1, Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)
  NCT07290244 · Phase: Phase 1 · Ages: 40 Years to 85 Years · Sex: All (male and female) · 4 locations
• Feasibility of Semaglutide in Advanced Lung Disease
  NCT05746039 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
  NCT06921317 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
  NCT07644364 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)
  NCT07123779 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
  NCT04624490 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 2 locations
• MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction
  NCT07183384 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 50 Years · Sex: Female · 1 location
• Metabolic Effects of Angiotensin-(1-7)
  NCT02646475 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
  NCT02648009 · Phase: Phase 1 · Ages: 19 Years to 75 Years · Sex: All (male and female) · 2 locations
• Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn
  NCT04898114 · Phase: Phase 1, Phase 2 · Ages: 6 Hours to 72 Hours · Sex: All (male and female) · 1 location
• Nesiritide in Hypertension
  NCT02608996 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 3 locations
• Phase 1 Clinical Study of MWX401 Injection in Chinese Healthy Participants and Participants With Mild Hypertension
  NCT07803835 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Polypill for Prevention of Cardiomyopathy
  NCT06143566 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Preliminary Human Trials of F230 Tablets
  NCT06899815 · Phase: Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
  NCT07051603 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease
  NCT07483372 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
  NCT07036510 · Phase: Phase 1, Phase 2 · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers
  NCT07282145 · Phase: Phase 1 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults
  NCT06429930 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study of Intravenous ZMA001 in Healthy Subjects
  NCT05967299 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
  NCT06823947 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations
• Sympathetic Mechanisms in Obesity-Crossover Design
  NCT05312892 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
  NCT04715022 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 65 Years · Sex: All (male and female) · 1 location
• Targeting Endoplasmic Reticulum Stress in Human Hypertension
  NCT06025630 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension
  NCT07191899 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Topical Insulin for Glaucoma
  NCT05206877 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting
  NCT05694858 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
  NCT06947473 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 65 Years · Sex: All (male and female) · 1 location
• Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study
  NCT06555393 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
  NCT07254481 · Phase: Phase 1 · Ages: 18 Years to 50 Years · Sex: All (male and female) · 2 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.